Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1,986 | 2,133 | 1,031 | -1,165 | 1,869 |
| Income taxes - deferred | -50 | 268 | 118 | 1,382 | 45 |
| Accounts receivable | 2,251 | -5,593 | 1,818 | 3,167 | -414 |
| Other Working Capital | 1,344 | -4,848 | 893 | 6,023 | -4,686 |
| Other Operating Activity | -3,014 | 7,905 | -2,594 | -3,684 | 1,209 |
| Operating Cash Flow | $2,518 | $-135 | $1,266 | $5,724 | $-1,977 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -533 | -862 | -1,179 | -327 | -1,950 |
| Purchase Of Investment | -825 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | -543 | 0 | 0 | 0 |
| Investing Cash Flow | $-1,358 | $-1,405 | $-1,179 | $-327 | $-1,950 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -614 | -525 | -422 | N/A | N/A |
| Dividend Paid | N/A | N/A | N/A | -544 | N/A |
| Other Financing Activity | 0 | 0 | 0 | -300 | -1,226 |
| Financing Cash Flow | $-614 | $-525 | $-422 | $-844 | $-1,226 |
| Exchange Rate Effect | -38 | -30 | 6 | 69 | N/A |
| Beginning Cash Position | 2,844 | 4,515 | 4,844 | 2,325 | 8,065 |
| End Cash Position | 3,806 | 2,844 | 4,515 | 5,025 | 2,325 |
| Net Cash Flow | $545 | $-2,066 | $-335 | $4,553 | $-5,153 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,518 | -135 | 1,266 | 5,724 | -1,977 |
| Capital Expenditure | -537 | -864 | -1,201 | -365 | -2,017 |
| Free Cash Flow | 1,981 | -1,000 | 65 | 5,358 | -3,994 |